Bank of Montreal
BBNX

Bank of Montreal’s Beta Bionics BBNX Stock Holding History

Bank of Montreal’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$135K Buy
13,522
+661
+5% +$9.78K ﹤0.01% 3053
2025
Q4 		$392K Buy
12,861
+2,636
+26% +$70.4K ﹤0.01% 2433
2025
Q3 		$203K Buy
+10,225
New +$180K ﹤0.01% 2772

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of Montreal's BBNX Position: Q1 2026 in Review

Bank of Montreal increased its Beta Bionics (BBNX) stake by 5.1% in Q1 2026, buying an estimated $9.78K and bringing the position to 13,522 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3053.

Bank of Montreal first reported a position in BBNX in Q3 2025 and has held it in 3 quarters since. The position peaked at $392K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Bank of Montreal held 13,522 shares of Beta Bionics worth $135K as of Q1 2026.
  • Bank of Montreal bought 661 Beta Bionics shares in Q1 2026, an estimated $9.78K.
  • Beta Bionics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3053 holding.
  • Bank of Montreal first reported a position in Beta Bionics in Q3 2025 and has held it in 3 quarters since.
  • Bank of Montreal's Beta Bionics position peaked at $392K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.